| Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation (NCT04804267) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-03-05 |
| Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation (NCT03879239) | Vibrant Ltd. | 2019-04-08 |
| Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC) (NCT04458675) | Vibrant Ltd. | 2018-07-26 |
| A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE® (NCT03551873) | Bausch Health Americas, Inc. | 2018-06-21 |
| Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo (NCT03097861) | Sucampo Pharma Americas, LLC | 2017-03-13 |
| The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation (NCT03054506) | Massachusetts General Hospital | 2017-03-07 |
| An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation (NCT03120520) | Bausch Health Americas, Inc. | 2017-01-01 |
| BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults (NCT02819297) | Braintree Laboratories | 2016-06-01 |
| An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults (NCT02819310) | Braintree Laboratories | 2016-06-01 |
| An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation (NCT02590432) | Forest Laboratories | 2015-11-01 |
| A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults (NCT02481947) | Braintree Laboratories | 2015-05-01 |
| Elobixibat Colonic Motor Function Study (NCT02392546) | Ferring Pharmaceuticals | 2015-04-01 |
| Trial of Linaclotide in Patients With Chronic Idiopathic Constipation (NCT02291679) | Ironwood Pharmaceuticals, Inc. | 2014-10-01 |
| Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation (NCT02361749) | Cairo University | 2014-09-01 |
| Efficacy of Linaclotide to Senna for CIC (NCT02239510) | TriHealth Inc. | 2014-09-01 |
| Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals (NCT02030756) | Vibrant Ltd. | 2014-07-01 |
| 12-Week Study of Plecanatide for CIC (The National CIC3 Study) (NCT02122471) | Bausch Health Americas, Inc. | 2014-04-01 |
| 12-Week Study of Plecanatide for CIC (The CIC3 Study) (NCT01982240) | Bausch Health Americas, Inc. | 2013-11-01 |
| Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation (NCT01993875) | Mallinckrodt | 2013-10-01 |
| Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation (NCT01895543) | Ferring Pharmaceuticals | 2013-09-01 |
| Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) (NCT01919697) | Bausch Health Americas, Inc. | 2013-08-01 |
| 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation (NCT01827592) | Ferring Pharmaceuticals | 2013-04-01 |
| Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation (NCT01833065) | Ferring Pharmaceuticals | 2013-04-01 |
| Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation (NCT01674530) | Dr. Reddy's Laboratories Limited | 2012-10-01 |
| The Plecanatide Chronic Idiopathic Constipation (CIC) Study (NCT01429987) | Bausch Health Americas, Inc. | 2011-10-01 |
| Evaluation of Clinical Equivalence Between Two Lubiprostone Products (NCT01372423) | Anchen Pharmaceuticals, Inc | 2011-05-01 |
| SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation (NCT01053962) | Bausch Health Americas, Inc. | 2010-03-01 |
| Domperidone for Relief of Gastrointestinal Disorders (NCT00761254) | Carle Physician Group | 2008-08-01 |
| Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation (NCT01460225) | Dartmouth-Hitchcock Medical Center | 2007-09-01 |
| A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation (NCT00511771) | Novartis | |